Correlation Between C4/IgG with Macroproteinuria in Chronic Kidney Disease: A Pilot Study

References

• Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379:815–822.
   PubMed Web of Science ®Google Scholar
• Fuhrman DY, Schneider MF, Dell KM, et al. Albuminuria, proteinuria, and renal disease progression in children with CKD. Clin J Am Soc Nephrol. 2017;12:912–920. doi:10.2215/CJN.11971116
   PubMed Web of Science ®Google Scholar
• Palmer SC, Strippoli GF. Proteinuria: does vitamin D treatment improve outcomes in CKD? Nat Rev Nephrol. 2013;9(11):638–640. doi:10.1038/nrneph.2013.209
   PubMed Web of Science ®Google Scholar
• Cravedi P, Ruggenenti P, Remuzzi G. Proteinuria should be used as a surrogate in CKD. Nat Rev Nephrol. 2012;8:301–306. doi:10.1038/nrneph.2012.42
   PubMed Web of Science ®Google Scholar
• Tangri N, Stevens LA, Griffith J, et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA. 2011;305:1553–1559. doi:10.1001/jama.2011.451
   PubMed Web of Science ®Google Scholar
• Bay JT, Schejbel L, Madsen HO, Sørensen SS, Hansen JM, Garred P. Low C4 gene copy numbers are associated with superior graft survival in patients transplanted with a deceased donor kidney. Kidney Int. 2013;84:562–569. doi:10.1038/ki.2013.195
   PubMed Web of Science ®Google Scholar
• Zhu B, Zhu CF, Lin Y, et al. Clinical characteristics of IgA nephropathy associated with low complement 4 levels. Ren Fail. 2015;37:424–432. doi:10.3109/0886022X.2014.994408
   PubMed Web of Science ®Google Scholar
• Persson U, Truedsson L, Westman KW, Segelmark M. C3 and C4 allotypes in anti-neutrophil cytoplasmic autoantibody (ANCA)-positive vasculitis. Clin Exp Immunol. 1999;116:379–382. doi:10.1046/j.1365-2249.1999.00889.x
   PubMed Web of Science ®Google Scholar
• Jüptner M, Flachsbart F, Caliebe A, et al. Low copy numbers of complement C4 and homozygous deficiency of C4A may predispose to severe disease and earlier disease onset in patients with systemic lupus erythematosus. Lupus. 2018;27:600–609. doi:10.1177/0961203317735187
   PubMed Web of Science ®Google Scholar
• Sethi S, Quint PS, O’Seaghdha CM, et al. C4 glomerulopathy: a disease entity associated with C4d deposition. Am J Kidney Dis. 2016;67(6):949–953. doi:10.1053/j.ajkd.2016.01.012
   PubMed Web of Science ®Google Scholar
• Dodder NG, Tai SS, Sniegoski LT, Zhang NF, Welch MJ. Certification of creatinine in a human serum reference material by GC-MS and LC-MS. Clin Chem. 2007;53:1694–1699. doi:10.1373/clinchem.2007.090027
   PubMed Web of Science ®Google Scholar
• Shlipak MG, Sri Lekha Tummalapalli LEB, Grams ME, et al.; Conference Participants. The case for early identification and intervention of chronic kidney disease: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int. 2021;99(1):34–47. doi:10.1016/j.kint.2020.10.012
   PubMed Web of Science ®Google Scholar
• Stevens LA, Claybon MA, Schmid CH, et al. Evaluation of the chronic kidney disease epidemiology collaboration equation for estimating the glomerular filtration rate in multiple ethnicities. Kidney Int. 2011;79:555–562. doi:10.1038/ki.2010.462
   PubMed Web of Science ®Google Scholar
• Collins AB, Schneeberger EE, Pascual MA, et al. Colvin RB Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol. 1999;10:2208–2214. doi:10.1681/ASN.V10102208
   PubMed Web of Science ®Google Scholar
• Nickeleit V, Zeiler M, Gudat F, Thiel G, Mihatsch MJ. Detection of the complement degradation product C4d in renal allografts: diagnostic and therapeutic implications. J Am Soc Nephrol. 2002;13:242–251. doi:10.1681/ASN.V131242
   PubMed Web of Science ®Google Scholar
• van de Lest NA, Zandbergen M, Wolterbeek R, et al. Glomerular C4d deposition can precede the development of focal segmental glomerulosclerosis. Kidney Int. 2019;96:738–749. doi:10.1016/j.kint.2019.04.028
   PubMed Web of Science ®Google Scholar
• Liao T, Zhang Y, Ren J, et al. Noninvasive quantification of intrarenal allograft C4d deposition with targeted ultrasound imaging. Am J Transplant. 2019;19:259–268. doi:10.1111/ajt.15105
   PubMed Web of Science ®Google Scholar
• Li SJ, Liu ZH, Zen CH, Wang QW, Wang Y, Li LS. Peritubular capillary C4d deposition in lupus nephritis different from antibody-mediated renal rejection. Lupus. 2007;16:875–880. doi:10.1177/0961203307083279
   PubMed Web of Science ®Google Scholar
• Gou SJ, Yuan J, Chen M, Yu F. Zhao MH.Circulating complement activation in patients with -----anti-neutrophil cytoplasmic antibody-associated vasculitis. Kidney Int. 2013;83:129–137. doi:10.1038/ki.2012.313
   PubMed Web of Science ®Google Scholar
• Espinosa M, Ortega R, Gómez-Carrasco JM, et al. Mesangial C4d deposition: a new prognostic factor in IgA nephropathy. Nephrol Dial Transplant. 2009;24:886–891. doi:10.1093/ndt/gfn563
   PubMed Web of Science ®Google Scholar
• Park JM, Lee H, Song S, et al. Primary Glomerulonephritis with Unique C4d Deposition and concurrent non-infectious intermediate uveitis: a case report and literature review. J Korean Med Sci. 2018;33:e136. doi:10.3346/jkms.2018.33.e136
   PubMed Web of Science ®Google Scholar
• Bi TD, Zheng JN, Zhang JX, et al. Serum complement C4 is an important prognostic factor for IgA nephropathy: a retrospective study. BMC Nephrol. 2019;20:244. doi:10.1186/s12882-019-1420-0
   PubMed Web of Science ®Google Scholar
• Pan M, Zhang J, Li Z, et al. Increased C4 and decreased C3 levels are associated with a poor prognosis in patients with immunoglobulin A nephropathy: a retrospective study. BMC Nephrol. 2017;18:231. doi:10.1186/s12882-017-0658-7
   PubMed Web of Science ®Google Scholar